Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 668 is a Krüppel-type C2H2 zinc finger transcription factor characterized by 16 C2H2-type zinc finger domains and is located in the nucleus. ZNF668 functions as a tumor suppressor, regulating p53 stability and DNA repair by interacting with the ubiquitin ligase MDM2, thereby protecting p53 from degradation. Its molecular activity supports chromatin relaxation and loading of DNA repair proteins upon damage, including homologous recombination repair. Mutations or reduced expression of ZNF668 have been associated with increased invasiveness and poorer prognosis in breast and bladder cancers, and germline mutations cause neurodevelopmental disorders. It is primarily studied as a cancer-relevant transcription factor but may also be involved in other processes linked to DNA regulation and chromatin structure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 668 (ZNF668).